CoChat

A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression

de Jonghe, F., Ravelli, D., Tuynman-Qua, H. · 1991 · Pharmacopsychiatry
Cited by 36

The DOI matches its Crossref record.

Abstract

In a six-week double-blind randomized trial, preceded by a one-week single-blind placebo treatment, the efficacy and the side-effects of fluoxetine (40 - 80 mg/d) (n = 30) and maprotiline (50 -150 mg/d) (n = 35) were compared in hospitalized patients with DSM-III Major Depression without psychotic features. Efficacy was measured by means of the Hamilton Depression Rating Scale, the Raskin Depression Scale, the Covi Anxiety Scale, and a Clinical Global Impression. Side-effects were evaluated by an Adverse Events Scale. A statistically significant improvement was achieved in both treatment groups but success rates were modest. No differences in efficacy were found between the two groups. In addition, no statistically significant differences were found between the two groups either in frequency or in severity of adverse events. In fact, the only statistically significant difference found was in weight change: weight loss in the fluoxetine group and weight gain in the maprotiline group. Zusammenfassung Die Effektivität und die Nebenwirkungen von Fluoxetine (40 - 80 mg pro Tag) (n = 30) und Maprotiline (50 -150 mg pro Tag) (n = 35) wurden miteinander verglichen in einer 6 Wochen dauernden randomisierten Doppelblind-Studie, vorhergegangen war eine Woche Enkelblind- Behandlung mit Plazebo. Die untersuchte Gruppe bestand aus 65 hospitalisierten Patienten mit als DSM-III-Diagnose ,,Major Depression" ohne psychotische Kennzeichen. Die Effektivität wurde gemessen mittels der ,,Hamilton Depression Scala", der ,,Raskin Depression Scala", der ,,Covi Angst Scala" und der ,,Globale klinische Eindruck". Die Nebenwirkungen wurden gemessen mittels einer ,,Nebenwirkungen- Skala". Die beiden Behandlungsgruppen erreichten eine statistisch signifikante Verbesserung, aber der therapeutische Sukzeß war bescheiden. Es gab keine Unterschiede hinsichtlich Effektivität und Nebenwirkungen, weder im qualitativen noch im quantitativen Sinn, zwischen den zwei Gruppen. Der einzige statistisch signifikante Unterschied betraf Körpergewichtsveränderungen: Gewichtsverminderung in der Fluoxetine-Gruppe und Gewichtszunahme in der Maprotiline-Gruppe.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-2007-1014440

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 36

Metadata

Authors
de Jonghe, F., Ravelli, D., & Tuynman-Qua, H.
Venue
Pharmacopsychiatry
Published
1991-03
Volume
24
Issue
02
Pages
62-67
ISSN
  • 0176-3679 (ISSN-L)
  • 1439-0795
OpenAlex
W2059459230
Cited by
36
References
0
FWCI
1.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression. https://app.cochat.ai/papers/10.1055/s-2007-1014440
The paper
de Jonghe, F., Ravelli, D., & Tuynman-Qua, H. (1991). A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression. Pharmacopsychiatry. https://doi.org/10.1055/s-2007-1014440

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.